"Today, Maryland Oncology Hematology is the largest independent Medical Oncology and Hematology group in Maryland with 30 physicians practicing in 9 locations across central Maryland. Dedicated to providing the most advanced cancer care availble anywhere in an atmosphere of caring compassion."

During the past decade, Maryland Oncology Hematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Maryland Oncology Hematology" are "Cancer" (1 trials), "Early Detection of Cancer" (1 trials) and "SARS-CoV-2 Infection" (1 trials). Many other conditions were trialed in "Maryland Oncology Hematology" in a lesser frequency.

Most popular intervention types in "Maryland Oncology Hematology" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Evusheld (tixagevimab+cilgavimab) IM or IV" (1 trials) and "Multi-Cancer Early Detection Test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maryland Oncology Hematology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Maryland Oncology Hematology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Maryland Oncology Hematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maryland Oncology Hematology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".